News

Thermo Fisher Scientific, the world leader in serving science, and Protein Metrics, a developer of world-class software tools for protein characterization, have entered into a non-exclusive co-marketing agreement to provide advanced mass spectrometry data processing and analysis capabilities to...

The Japanese pharmaceutical market is preparing for renewed international growth and partnering. In response, CPhI Japan has opened a two-month long virtual event to meet demand from international pharma. Informa introduced CPhI Japan Connect – a new virtual platform for...

Vibalogics, a global contract development and manufacturing organization (CDMO) specializing in the production of virotherapy products, has strengthened its North American team with new strategic hires, including a Chief Financial Officer (CFO), Vice President of Quality and Head of...

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Virchow Biotech Private Limited (part of the Virchow Group), one of the leading vaccine and pharmaceutical producers in India, announce the agreement to produce in the country up...

Boston Pharmaceuticals announced a pioneering three-year out-license and option agreement with GlaxoSmithKline PLC. Boston Pharmaceuticals will become a preferred GSK partner for select pre-phase 2 programs. This new agreement builds on the relationship established in 2018 with Boston Pharmaceuticals’...

The Hungarian National Institute of Pharmacy and Nutrition has granted approval for the emergency use of Chinese company CanSino Biologics’ Covid-19 vaccine. Named Convidecia, the vaccine is made upon an adenovirus-based viral vector vaccine technology platform and uses a single-dose...

The US FDA has approved the Janssen Pharmaceutical Companies of Johnson & Johnson’s (JNJ) PONVORY (ponesimod) for treating adults with relapsing forms of multiple sclerosis (MS). PONVORY is a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator. The approval will...